Details of the Metabolic Reaction (MR)
| General Information of This Metabolic Reaction (MR) (ID: MR008626) | ||||||
|---|---|---|---|---|---|---|
| Formula |
  Unclear
 |
|||||
| Reactant | Tazemetostat | Product | EPZ006931 | |||
| Reactant Info | Product Info | |||||
| Metabolic Type | Unclear - Unclear | |||||
| Other MR(s) Related to The Reactant of This MR | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other MR(s) That Metabolize The Reactant of This MR | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| References | ||||||
|---|---|---|---|---|---|---|
| 1 | Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.